Fast, easy, automated clinical NGS workflow goes from nucleic acid to report in as little as 24 hours
Targeted next‑generation sequencing (NGS) has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic sequencing with faster turnaround times, reduced tumor specimen requirements, and increased ease of use, requiring less training and hands on time. As a result, NGS has now become accessible to a broad spectrum of laboratories, bringing testing closer to the patient.
Delivering on our mission to make NGS accessible to all labs, Thermo Fisher Scientific is proud to announce the launch of the CE‑IVD marked Ion Torrent Genexus Dx Integrated Sequencer. Watch this on‑demand webinar to learn more about the Genexus Dx Integrated Sequencer and how it allows you to go from nucleic acid to NGS report in as little as 24 hours.
Topics covered include:
- The importance of fast NGS for clinical labs
- How the Genexus Dx Integrated Sequencer delivers NGS results in as little as 24 hours
- Thermo Fisher Scientific's commitment to clinical next‑generation sequencing
Speakers:
Andy Felton, Ph.D.
Vice President of Product Management and Market Development for the Clinical Sequencing Division; Thermo Fisher Scientific
Dr. Luca Quagliata, Ph.D., BCMAS
Vice President, Medical Affairs; Thermo Fisher Scientific
Kathy Davy
Vice President of the Translational and Clinical Oncology in the Clinical Sequencing Division, Thermo Fisher Scientific
Not available in all countries including the United States.